 
        
        
        
                货号:A190057
                
                同义名:
                    
                        
                            D(-)-水杨苷
                            
                             / Salicoside; D-(-)-Salicin
                            
                        
                    
                
                
                
                    
                     
                    
                     
                
            
Salicin是一种非选择性的 COX-1 和 COX-2 抑制剂,是从白柳(Salix alba L.)的树皮中提取的苯酚 β-糖苷,具有抗炎作用。
 
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 产品名称 | COX ↓ ↑ | COX-1 ↓ ↑ | COX-2 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Piroxicam | ✔ | 98% | |||||||||||||||||
| Salicylic acid | ✔ | 98% | |||||||||||||||||
| Phenacetin | ✔ | 98% | |||||||||||||||||
| Etodolac | ✔ | 99% | |||||||||||||||||
| Flunixin meglumine | ✔ | 98% | |||||||||||||||||
| Ibuprofen L-lysine | ✔ | 98% | |||||||||||||||||
| Nabumetone | ✔ | 98% | |||||||||||||||||
| Acemetacin | ✔ | 98% | |||||||||||||||||
| Diflunisal | ✔ | 98% | |||||||||||||||||
| Pranoprofen | ✔ | 98% | |||||||||||||||||
| Ampiroxicam | ✔ | 98% | |||||||||||||||||
| Meloxicam | ✔ | 98% | |||||||||||||||||
| Sulindac | ✔ | 98% | |||||||||||||||||
| Ketoprofen | ✔ | 98% | |||||||||||||||||
| Mefenamic Acid | ✔ | 95% | |||||||||||||||||
| Bromfenac sodium | ✔ | 98% | |||||||||||||||||
| Oxaprozin | ✔ | 99% | |||||||||||||||||
| Aspirin | ✔ | 99% | |||||||||||||||||
| Nepafenac | ✔ | 98% | |||||||||||||||||
| Zaltoprofen | ✔ | 99% | |||||||||||||||||
| Salicin | ✔ | 98% | |||||||||||||||||
| Suprofen | ✔ | 99%+ | |||||||||||||||||
| Xanthohumol | ✔ | 99% | |||||||||||||||||
| Parecoxib | ✔ | 98% | |||||||||||||||||
| Tolfenamic Acid | +++ COX-2, IC50: 0.2 μM | 98% | |||||||||||||||||
| Etoricoxib | ✔ | 99% | |||||||||||||||||
| Niflumic Acid | ✔ | 98% | |||||||||||||||||
| Valdecoxib | ++++ COX-2, IC50: 5 nM | 99+% | |||||||||||||||||
| Ibuprofen | + COX-1, IC50: 13 μM | + COX-2, IC50: 370 μM | 98% | ||||||||||||||||
| Indomethacin | ++ COX1, IC50: 0.28 μM | + COX-2, IC50: 14 μM | 97% | ||||||||||||||||
| Lornoxicam | ++++ COX-1, IC50: 5 nM | ++++ COX-2, IC50: 8 nM | 98% | ||||||||||||||||
| Meclofenamic acid sodium | ++++ COX-1, IC50: 40 nM | +++ COX-2, IC50: 50 nM | 99% | ||||||||||||||||
| Asaraldehyde | ✔ | 98% | |||||||||||||||||
| Naproxen | + COX-1, IC50: 8.7 μM | + COX-2, IC50: 5.2 μM | 98% | ||||||||||||||||
| Diclofenac Sodium Salt | +++ COX-1, IC50: 60 nM | +++ COX-2, IC50: 200 nM | 98% | ||||||||||||||||
| NS-398 | ++ COX-2, IC50: 3.8 μM | 95% | |||||||||||||||||
| Amfenac Sodium Hydrate | ++ COX-1, IC50: 250 nM | +++ COX-2, IC50: 150 nM | 98%+ | ||||||||||||||||
| Nimesulide | + COX-2, IC50: 26 μM | 98% | |||||||||||||||||
| Lumiracoxib | ++ COX-1, Ki: 3 μM | +++ COX-2, Ki: 60 nM | 98% | ||||||||||||||||
| Rutaecarpine | ✔ | 95% | |||||||||||||||||
| Celecoxib | ++++ COX-2, IC50: 40 nM | 98% | |||||||||||||||||
| Carprofen | ++++ canine COX2, IC50: 30 nM | 98% | |||||||||||||||||
| Ketorolac | ++ COX-1 (human), IC50: 1.23 μM | ++ COX-2 (human), IC50: 3.50 μM | 98% | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 | 
 | 
| 描述 | Salicin is a natural COX inhibitor. At the cellular level, salicin attenuates IL-1β-induced mitochondrial injury as revealed by its preservation on mitochondrial membrane potential (MMP). Furthermore, salicin inhibits IL-1β-induced production of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1), vascular adhesion molecules such as intercellular cell adhesion molecule-1 (iCAM-1) and vascular cell adhesion molecule 1 (VCAM-1), and high-mobility group protein 1 (HMGB-1) [3]. Salicin significantly reduced cell viability, cytokines, and matrix metalloproteinases-1/-3 expression in IL-1β-induced RA-FLSs and inhibited ROS generation and p65 phosphorylation as compared with IL-1β-induced treatment. Moreover, salicin promoted Nrf2 nuclear translocation and HO-1 expression and reduced ROS production in IL-1β-induced RA-FLSs[4]. | 
| Concentration | Treated Time | Description | References | |
| HEK293 cells | 10 mM | To validate whether Salicin can activate calcium signaling in HEK293 cells via Tas2r143, results showed that Salicin induced an increase in intracellular calcium. | Front Immunol. 2024 Mar 28;15:1374900. | |
| Mouse gingival fibroblasts (MGFs) | 10 mM | 12 h | To investigate the inhibitory effect of Salicin on LPS-induced chemokine expression in MGFs, results showed that Salicin significantly down-regulated the expression of CXCL1, CXCL2, and CXCL5. | Front Immunol. 2024 Mar 28;15:1374900. | 
| proximal colonic epithelial cells | 5 mM | 7 days | stimulate proximal colonic epithelial cells to release IL-25 and induce tuft cell proliferation | Front Immunol. 2023 Oct 25;14:1259521. | 
| Administration | Dosage | Frequency | Description | References | ||
| Mongolian gerbils | Transient forebrain ischemia model | Intraperitoneal injection | 20 mg/kg | Once daily for 3 days | Salicin significantly protected hippocampal CA1 pyramidal neurons from ischemic injury by attenuating oxidative stress and activating the PI3K/Akt/GSK3β pathway. | Antioxidants (Basel). 2021 Apr 20;10(4):629 | 
| Mice | Ligature-induced periodontitis (LIP) mouse model | Topical application | 100 mg/kg | Twice a day for 7 days | To investigate the effect of Salicin on periodontitis via taste transduction pathway, results showed that Salicin significantly inhibited periodontal bone loss and inflammatory factor expression, but these effects were abolished in Gnat3-/- mice. | Front Immunol. 2024 Mar 28;15:1374900. | 
| Mice | Proximal colonic tuft cell model | Anal administration | 5 mM | Twice a day for 7 days | Promote proximal colonic tuft cell proliferation by activating Tas2r receptors | Front Immunol. 2023 Oct 25;14:1259521. | 
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 | 
| NCT01920841 | Weight Loss | Not Applicable | Withdrawn(Study Design changed... 展开 >> and will be resubmitted as a new study) 收起 << | - | United States, Louisiana ... 展开 >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 收起 << | 
| NCT01956500 | Joint Pain, Stiffness, Functio... 展开 >>n 收起 << | Not Applicable | Completed | - | United States, North Carolina ... 展开 >> ASU Human Performance Laboratory, North Carolina Research Campus Kannapolis, North Carolina, United States, 28081 收起 << | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 3.49mL 0.70mL 0.35mL | 17.47mL 3.49mL 1.75mL | 34.93mL 6.99mL 3.49mL | |
| CAS号 | 138-52-3 | 
| 分子式 | C13H18O7 | 
| 分子量 | 286.28 | 
| SMILES Code | O[C@@H]1[C@@H](CO)O[C@@H](OC2=CC=CC=C2CO)[C@H](O)[C@H]1O | 
| MDL No. | MFCD00006590 | 
| 别名 | D(-)-水杨苷 ;Salicoside; D-(-)-Salicin; NSC 5751 | 
| 运输 | 蓝冰 | 
| InChI Key | NGFMICBWJRZIBI-UJPOAAIJSA-N | 
| Pubchem ID | 439503 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, room temperature | 
| 溶解方案 | DMSO: 145 mg/mL(506.5 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 12 mg/mL(41.92 mM),配合低频超声,并水浴加热至45℃助溶 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1